8/28 論文

① Major Bleeding Postadministration of Tenecteplase Versus Alteplase in Acute Ischemic Stroke.
Walton MN, Hamilton LA, Salyer S, Wiseman BF, Forster AM, Rowe AS.
Ann Pharmacother. 2022 Aug 24:10600280221120211. doi: 10.1177/10600280221120211. Online ahead of print.
PMID: 36004394

② Perioperative Antiplatelet Bridging With Cangrelor: A Cohort Study and Narrative Review.
Salgia A, Krueger CK, Gillette MA.
Ann Pharmacother. 2022 Aug 24:10600280221120310. doi: 10.1177/10600280221120310. Online ahead of print.
PMID: 36004393

③ Group based trajectory modeling to assess adherence to oral anticoagulants among atrial fibrillation patients with comorbidities: a retrospective study.
Mohan A, Majd Z, Trinh T, Paranjpe R, Abughosh SM.
Int J Clin Pharm. 2022 Aug;44(4):966-974. doi: 10.1007/s11096-022-01417-4. Epub 2022 Jul 1.
PMID: 35776377

④ Antiplatelet Use in Ischemic Stroke.
Kamarova M, Baig S, Patel H, Monks K, Wasay M, Ali A, Redgrave J, Majid A, Bell SM.
Ann Pharmacother. 2022 Oct;56(10):1159-1173. doi: 10.1177/10600280211073009. Epub 2022 Jan 29.
PMID: 35094598 Free PMC article. Review.

⑤ Tirzepatide: First Approval.
Syed YY.
Drugs. 2022 Jul;82(11):1213-1220. doi: 10.1007/s40265-022-01746-8.
PMID: 35830001 Review.

⑥ Potentially inappropriate prescribing for adults living with diabetes mellitus: a scoping review.
Ayalew MB, Spark MJ, Quirk F, Dieberg G.
Int J Clin Pharm. 2022 Aug;44(4):860-872. doi: 10.1007/s11096-022-01414-7. Epub 2022 Jul 1.
PMID: 35776376 Free PMC article. Review.